Want to see IN:BOROSCI full AI Analyst Report?
Borosil Scientific Limited (BOROSCI) Ratios
Borosil Scientific Limited Ratios
IN:BOROSCI's free cash flow for Q4 2024 was $1.07B. For the 2024 fiscal year, IN:BOROSCI's free cash flow was decreased by $-81.76M and operating cash flow was $1.15B. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 25 |
|---|---|---|
| Liquidity Ratios | ||
| Current Ratio | 3.56 | 3.62 |
| Quick Ratio | 2.45 | 2.50 |
| Cash Ratio | 0.15 | 0.15 |
| Solvency Ratio | 0.43 | 0.50 |
| Operating Cash Flow Ratio | 1.38 | 0.46 |
| Short-Term Operating Cash Flow Coverage | 9.69 | 5.83 |
| Net Current Asset Value | $ 2.06B | $ 2.28B |
| Leverage Ratios | ||
| Debt-to-Assets Ratio | 0.03 | 0.02 |
| Debt-to-Equity Ratio | 0.04 | 0.02 |
| Debt-to-Capital Ratio | 0.03 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.24 |
| Debt Service Coverage Ratio | 3.36 | 6.53 |
| Interest Coverage Ratio | 22.43 | 38.08 |
| Debt to Market Cap | 0.01 | 0.01 |
| Interest Debt Per Share | 1.80 | 1.10 |
| Net Debt to EBITDA | 0.02 | -0.08 |
| Profitability Margins | ||
| Gross Profit Margin | 47.04% | 43.02% |
| EBIT Margin | 9.60% | 9.41% |
| EBITDA Margin | 13.82% | 13.53% |
| Operating Profit Margin | 7.93% | 9.19% |
| Pretax Profit Margin | 9.24% | 9.17% |
| Net Profit Margin | 6.13% | 7.41% |
| Continuous Operations Profit Margin | 6.11% | 7.40% |
| Net Income Per EBT | 66.36% | 80.79% |
| EBT Per EBIT | 116.52% | 99.74% |
| Return on Assets (ROA) | 5.27% | 6.30% |
| Return on Equity (ROE) | 6.63% | 7.84% |
| Return on Capital Employed (ROCE) | 8.22% | 9.41% |
| Return on Invested Capital (ROIC) | 5.28% | 7.48% |
| Return on Tangible Assets | 6.07% | 7.18% |
| Earnings Yield | 2.46% | 3.77% |
| Efficiency Ratios | ||
| Receivables Turnover | 6.03 | 6.13 |
| Payables Turnover | 6.65 | 6.27 |
| Inventory Turnover | 2.40 | 2.58 |
| Fixed Asset Turnover | 3.58 | 3.58 |
| Asset Turnover | 0.86 | 0.85 |
| Working Capital Turnover Ratio | 0.00 | 2.01 |
| Cash Conversion Cycle | 157.89 | 142.86 |
| Days of Sales Outstanding | 60.56 | 59.57 |
| Days of Inventory Outstanding | 152.21 | 141.52 |
| Days of Payables Outstanding | 54.88 | 58.24 |
| Operating Cycle | 212.77 | 201.09 |
| Cash Flow Ratios | ||
| Operating Cash Flow Per Share | 13.51 | 4.77 |
| Free Cash Flow Per Share | 11.91 | 1.57 |
| Dividend Paid and CapEx Coverage Ratio | 8.47 | 1.49 |
| Capital Expenditure Coverage Ratio | 8.47 | 1.49 |
| Operating Cash Flow Coverage Ratio | 8.31 | 4.92 |
| Operating Cash Flow to Sales Ratio | 0.27 | 0.09 |
| Free Cash Flow Yield | 9.71% | 1.53% |
| Valuation Ratios | ||
| Price-to-Earnings (P/E) Ratio | 40.63 | 26.49 |
| Price-to-Sales (P/S) Ratio | 2.49 | 1.96 |
| Price-to-Book (P/B) Ratio | 2.70 | 2.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.30 | 65.46 |
| Price-to-Operating Cash Flow Ratio | 9.08 | 21.60 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.92 |
| Enterprise Value Multiple | 18.06 | 14.43 |
| Enterprise Value | 10.91B | 9.12B |
| EV to EBITDA | 18.06 | 14.43 |
| EV to Sales | 2.50 | 1.95 |
| EV to Free Cash Flow | 10.31 | 65.09 |
| EV to Operating Cash Flow | 9.09 | 21.47 |
| Tangible Book Value Per Share | 37.95 | 42.09 |
| Shareholders’ Equity Per Share | 45.51 | 49.60 |
| Tax and Other Ratios | ||
| Effective Tax Rate | 0.34 | 0.19 |
| Revenue Per Share | 49.19 | 52.52 |
| Net Income Per Share | 3.02 | 3.89 |
| Tax Burden | 0.66 | 0.81 |
| Interest Burden | 0.96 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 |
| SG&A to Revenue | 0.15 | 0.34 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 |
| Income Quality | 2.97 | 1.23 |
Currency in INR
